Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase III clinical trial update for minodronate tablets in postmenopausal osteoporosis; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minodronate (minodronate)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Osteoporosis | Phase 3 | Status: UNKNOWN